Entellus Medical Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Entellus Medical Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7220
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Entellus Medical Inc (Entellus Medical), a subsidiary of Stryker Corp, is a medical device company that offers invasive products for the treatment of chronic sinusitis. The company’s products include multi sinus dilation system, surgical instruments, sinonasal suction and irrigation system, fiagon system, sinuscopes, HD wireless camera, turbinate forceps, post-operative care products, medical shaver system, medical reinforced anesthesia needle, and others. Its post-operative care products provide nasal packing materials that are used to treat patients undergoing nasal or sinus surgery, and to treat epistaxis. Entellus Medical’s surgical instruments comprise sterilization tray, turbinate forceps, light seeker, maxillary seekers and sphenoid seeker. The company markets its products through a network of distributors in the US, Canada and other countries. Entellus Medical is headquartered in Plymouth, Minnesota, the US.

Entellus Medical Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Entellus Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Entellus Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Entellus Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Entellus Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Entellus Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Entellus Medical Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Entellus Medical Acquires XeroGel Assets from CogENT Therapeutics for USD11 Million 10
Venture Financing 11
Spirox Raises USD18.5 Million in Series B Financing 11
Nasoform Raises US$5.3 Million In Venture Financing 12
Private Equity 13
Spirox Raises USD45 Million in Series C Financing 13
Partnerships 15
Entellus Medical Enters into Co-Marketing Agreement with Xoran Technologies 15
Entellus Medical Expands Distribution Agreement with Fiagon 16
Entellus Medical Enters Into Distribution Agreement With CogENT Therapeutics For XeroGel 17
Equity Offering 18
Entellus Medical Plans to Raise up to USD172.3 Million in Public Offering of Shares 18
Entellus Medical Raises USD50 Million in Private Placement of Shares 19
Entellus Medical Raises USD60 Million in Public Offering of Shares 20
Entellus Medical Raises USD90 Million in IPO 22
Acquisition 24
Stryker Acquires Entellus Medical for USD662 Million 24
Entellus Medical Acquires Spirox from KKR Fund for USD81 Million 26
Entellus Medical Inc – Key Competitors 27
Entellus Medical Inc – Key Employees 28
Entellus Medical Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Nov 01, 2017: Entellus Medical Announces Third Quarter 2017 Financial Results 30
Aug 03, 2017: Entellus Medical Announces Second Quarter 2017 Financial Results 31
May 03, 2017: Entellus Medical Announces First Quarter 2017 Financial Results 32
Feb 21, 2017: Entellus Medical Announces Fourth Quarter and Full Year 2016 Financial Results 33
Jan 05, 2017: Entellus Medical Announces Management Promotions and Preliminary Revenue for Fourth Quarter and Full Year 2016 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Entellus Medical Inc, Medical Equipment, Key Facts 2
Entellus Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Entellus Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Entellus Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Entellus Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Entellus Medical Inc, Deals By Market, 2012 to YTD 2018 8
Entellus Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Entellus Medical Acquires XeroGel Assets from CogENT Therapeutics for USD11 Million 10
Spirox Raises USD18.5 Million in Series B Financing 11
Nasoform Raises US$5.3 Million In Venture Financing 12
Spirox Raises USD45 Million in Series C Financing 13
Entellus Medical Enters into Co-Marketing Agreement with Xoran Technologies 15
Entellus Medical Expands Distribution Agreement with Fiagon 16
Entellus Medical Enters Into Distribution Agreement With CogENT Therapeutics For XeroGel 17
Entellus Medical Plans to Raise up to USD172.3 Million in Public Offering of Shares 18
Entellus Medical Raises USD50 Million in Private Placement of Shares 19
Entellus Medical Raises USD60 Million in Public Offering of Shares 20
Entellus Medical Raises USD90 Million in IPO 22
Stryker Acquires Entellus Medical for USD662 Million 24
Entellus Medical Acquires Spirox from KKR Fund for USD81 Million 26
Entellus Medical Inc, Key Competitors 27
Entellus Medical Inc, Key Employees 28
Entellus Medical Inc, Subsidiaries 29

List of Figures
Entellus Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Entellus Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Entellus Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Entellus Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Entellus Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Entellus Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Entellus Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Entellus Medical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Entellus Medical Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Affimed GmbH (AFMD):企業の財務・戦略的SWOT分析
    Summary Affimed GmbH (Affimed), formerly Affimed Therapeutics AG, a subsidiary of Affimed NV, discovers and develops immunotherapies to treat hematologic cancers and solid tumors. The company is investigating AFM13, an innate cell engager, for the treatment of Peripheral T cell lymphoma, transformed …
  • China Tontine Wines Group Limited:企業の戦略・SWOT・財務情報
    China Tontine Wines Group Limited - Strategy, SWOT and Corporate Finance Report Summary China Tontine Wines Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • AltaGas Ltd.:企業のM&A・事業提携・投資動向
    AltaGas Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AltaGas Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • The Hour Glass Ltd (AGS):企業の財務・戦略的SWOT分析
    The Hour Glass Ltd (AGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Karus Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Karus Therapeutics Ltd (Karus) is a drug development company that designs and develops cancer therapies. The company offers small molecule drugs with immunotherapy for the treatment of hematological and solid tumors. Its pipeline products include KA2507 and KA2237 inhibitors. Karus’ KA2507 i …
  • Silgan Holdings Inc.:企業の戦略・SWOT・財務情報
    Silgan Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Silgan Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Pierrel Spa (PRL):製薬・医療:M&Aディール及び事業提携情報
    Summary Pierrel Spa (Pierrel) is a pharmaceutical company that offers contract services to biopharmaceutical and life sciences industries across the world. The company offers services in the areas of contract research, discovery of medicinal product candidates, clinical research and contract manufac …
  • Royal Caribbean Cruises Ltd.:戦略・SWOT・企業財務分析
    Royal Caribbean Cruises Ltd. - Strategy, SWOT and Corporate Finance Report Summary Royal Caribbean Cruises Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Chugoku Marine Paints, Ltd. (4617):企業の財務・戦略的SWOT分析
    Chugoku Marine Paints, Ltd. (4617) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Silver Spring Networks, Inc. (SSNI)-エネルギー分野:企業M&A・提携分析
    Summary Silver Spring Networks, Inc. (Silver Spring) is a smart grid networking platform technology and solutions provider. The company’s products include metering devices, network infrastructure, utilityIQ applications, GridScape software and customerIQ web portal. Silver Spring provides wide range …
  • Opthea Ltd (OPT):企業の財務・戦略的SWOT分析
    Summary Opthea Ltd (Opthea), formerly Circadian Technologies Ltd, is a biotechnology company that develops novel biologic therapy for the treatment of eye diseases. The company carries out research and development of angiogenesis and vascular leakage-based treatments for cancer concentrating on vasc …
  • Morneau Shepell Inc.:企業の戦略・SWOT・財務分析
    Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report Summary Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Caprion Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Caprion Biosciences Inc (Caprion) is a provider of proteomics and immune monitoring services. The company provides proteomic based services such as neo-epitope discovery and characterization, biomarker discovery, fit-for-purpose assays, host cell protein detection, PK assays, and others. It …
  • Wesfarmers Ltd (WES)-エネルギー分野:企業M&A・提携分析
    Summary Wesfarmers Limited (Wesfarmers) is a diversified company that has business operations in retail and industrial activities. Its retail activities include supermarkets, liquor, hotels and convenience stores; department stores; home improvement and office supplies; and apparel retailing. The co …
  • Belk Inc:企業の戦略・SWOT・財務情報
    Belk Inc - Strategy, SWOT and Corporate Finance Report Summary Belk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Dole Food Company Inc:企業のM&A・事業提携・投資動向
    Dole Food Company Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dole Food Company Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Covea Mutual Insurance Group Company:企業の戦略・SWOT・財務情報
    Covea Mutual Insurance Group Company - Strategy, SWOT and Corporate Finance Report Summary Covea Mutual Insurance Group Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Huawei Investment & Holding Co., Ltd.:企業のM&A・事業提携・投資動向
    Huawei Investment & Holding Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Huawei Investment & Holding Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Canara Bank (CANBK):企業の財務・戦略的SWOT分析
    Canara Bank (CANBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Electricity Supply Board:電力:M&Aディール及び事業提携情報
    Summary Electricity Supply Board (ESB) owned by Irish Government, is a diversified and vertically integrated utility that generates, transmits, and distributes and supplies electricity and gas. The company builds, owns and maintains transmission and distribution networks. It offers meter reading, an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆